Is Everything a Challenge for Multiple Sclerosis patients? Nonverbal Semantic Memory Performance in Iranian Relapsing-Remitting Multiple Sclerosis Patients

被引:0
|
作者
Yazdani, Sara [1 ]
Sharifi, Shahla [1 ]
Foroughipour, Mohsen [2 ]
Gol, Atiyeh Kamyabi [1 ]
机构
[1] Ferdowsi Univ Mashhand, Linguist Dept, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Neurol Dept, Gaem Hosp, Mashhad, Razavi Khorasan, Iran
来源
BANGLADESH JOURNAL OF MEDICAL SCIENCE | 2021年 / 20卷 / 02期
关键词
nonverbal information; semantic memory; Multiple sclerosis; Iran; COGNITIVE IMPAIRMENT; INFORMATION; NEURODEGENERATION; DEMYELINATION; DEMENTIA; DEFICITS;
D O I
10.3329/bjms.v20i2.51554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objective of the current study was to evaluate the nonverbal semantic memory performance of MS patients and compare it with their healthy counterparts. Materials and methods: In this study, 70 patients with definite relapsing-remitting multiple selerosis(15 men and 55 women) and 70 healthy individuals of comparable demographics (age, gender, and education) from patients' relatives and family members were selected based on convenient sampling. The patients recruited for this study were divided into two groups based on their Montreal Cognitive Assessment (MoCA) scores. The first group of patients (MS1) with MoCA scores of 18-25, and the MoCA scores of the second group (MS2) ranged from 10 -17. All of the participants were right-handed, originally born in Mashhad, Iran, and native speakers of Persian. To assess the nonverbal semantic memory performance of the participants, the picture version of The Camel and Cactus Test (CCT) was selected and administered from the Cambridge Semantic Memory battery test. Results: The results revealed that there was no significant difference between the MS1 and the Healthy Controls group in living and man-made variables, while MS2 performed significantly different compared to other groups in these variables. The results also showed that all three groups of participants performed significantly different from each other in reaction time variable. Conclusion: The findings showed that cognitive impairment in multiple sclerosis patients did not affect their nonverbal semantic memory performance, however, it had an impact on their reaction time.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 50 条
  • [1] Executive function and memory in patients with relapsing-remitting multiple sclerosis
    Cerezo Garcia, Marta
    Martin, Pilar
    Aladro Benito, Yolanda
    Balseiro Gomez, Jose Jesus
    Rueda Marcos, Almudena
    PSICOTHEMA, 2009, 21 (03) : 416 - 420
  • [2] Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
    Yavari, Fatemeh
    Oliazadeh, Pardis
    Radfar, Meisam
    Foroughipour, Mohsen
    Nikkhah, Karim
    Bakavoli, Alireza Heidari
    Saeidi, Morteza
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (02) : 233 - 242
  • [3] Clinical parameters at multiple sclerosis diagnosis and cognitive performance in relapsing-remitting multiple sclerosis patients
    Anabel Silva, Berenice
    Laura Saladino, Maria
    Eizaguirre, Barbara
    Alonso, Ricardo
    Cecilia Pita, Maria
    Merino, Angeles
    Yastremiz, Cecilia
    Cabral, Nadia
    Mariangeli, Aldana
    Vanotti, Sandra
    Garcea, Orlando
    Caceres, Fernando
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 151 - 152
  • [4] Memory for faces and emotion recognition in patients with relapsing-remitting multiple sclerosis
    Goettfried, E.
    Berek, K.
    Herzog, M.
    Seebacher, B.
    Auer, M.
    Di Pauli, F.
    Hegen, H.
    Fava, E.
    Zinganell, A.
    Delazer, M.
    Deisenhammer, F.
    Zamarian, L. Laura
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 188 - 188
  • [5] Objective and subjective prospective memory in relapsing-remitting multiple sclerosis patients
    Valeria Cores, Evangelina
    Vanotti, Sandra
    Osorio, Mabel
    Gustavo Politis, Daniel
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 165 - 165
  • [6] Differential patterns of memory performance in relapsing-remitting and secondary progressive multiple sclerosis patients
    Drake, M
    Carrá, A
    Allegri, B
    Luetic, G
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S124 - S124
  • [7] MICROBIOME CORE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Navarro-Lopez, V.
    Mingot, J. M.
    Carrion-Gutierrez, M.
    Paya-Espinosa, Y.
    Ruzafa Costa, B.
    Nunez Delegido, E.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 56 - 57
  • [8] Cognitive impairment in relapsing-remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Yandim-Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406
  • [9] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [10] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Omerzu, Tomaz
    Magdic, Jozef
    Hojs, Radovan
    Potocnik, Uros
    Gorenjak, Mario
    Fabjan, Tanja Hojs
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (1-2) : 40 - 47